XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.21.2

DERIVATIVE LIABILITIES | 9 Months Ended
--- | ---
Jun. 30, 2021
DERIVATIVE LIABILITIES |
DERIVATIVE LIABILITIES | 9. DERIVATIVE LIABILITIES In January 2016, the Company completed a private placement of 227,273 units of the Company at $66.00 per unit (“Unit”) for gross proceeds of $14,999,992. Each Unit consisted of one common share of the Company, one 7-year cash and cashless exercise warrant (the “7-Year Warrants”), and one half of one 2-year cash exercise warrant (the “2-Year Warrants”). The 7-Year Warrants and 2-Year Warrants have an exercise price of $66.00 per common share (collectively, the “2016 Warrants”). The holders of the 7-Year Warrants may elect, in lieu of exercising the 7-Year Warrants for cash, a cashless exercise option, in whole or in part, to receive common shares equal to the fair value of the 7-Year Warrants based on the number of 7-Year Warrants to be exercised multiplied by a ten-day weighted average market price less the exercise price with the difference divided by the weighted average market price. If a warrant holder exercises this option, there will be variability in the number of shares issued per 7-Year Warrant. Additionally, the 2016 Warrants contain provisions which may require the Company to redeem the 2016 Warrants, at the option of the holder, in the event of a major transaction, such as a change of control or sale of the Company’s assets (“Major Transaction”). The redemption value would be subject to a Black-Scholes valuation at the time of exercise. In the event the consideration for a Major Transaction payable to the common shareholders is in cash, in whole or in part, the redemption of the 2016 Warrants would be made in cash pro-rata to the composition of the consideration. The potential for a cash settlement for the 2016 Warrants outside the control of the Company, in accordance with U.S. GAAP, requires the 2016 Warrants to be treated as financial liabilities measured at fair value through profit or loss. The 2016 Warrants are not traded in an active market. Valuation The Company uses the Black-Scholes option pricing model to estimate fair value. The following weighted average assumptions were used to estimate the fair value of the derivative warrant liabilities on June 30, 2021 and 2020: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​
​ | ​ | June 30, | ​ | ​ | June 30, | ​
​ | ​ | 2021 |  | ​ | 2020 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
Risk-free interest rate |  | 0.36 | % | ​ | 0.23 | %
Expected life |  | 1.54 | years | ​ | 2.54 | years
Expected annualized volatility |  | 70.8 | % | ​ | 86.9 | %
Dividend |  | — |  | ​ | — | ​
Liquidity discount |  | 20 | % | ​ | 20 | %
​ Sensitivity The derivative warrants are a recurring Level 3 fair value measurement. The key level 3 inputs used by management to determine the fair value are the market price, expected volatility and liquidity discount. If the market price were to increase by a factor of 10% this would increase the obligation by approximately $206,222 as of June 30, 2021. If the market price were to decrease by a factor of 10% this would decrease the obligation by approximately $186,074 as of June 30, 2021. If the volatility were to increase by 10%, this would increase the obligation by approximately $201,538 as of June 30, 2021. If the volatility were to decrease by 10%, this would decrease the obligation by approximately $192,930 as of June 30, 2021. The following table is a continuity schedule of changes to the Company’s derivative liabilities: ​
​ | ​ | ​ | ​
​ |  | Total
​ | ​ | ​ | ​
Balance, September 30, 2019 |  | $ | 16,520
Change in fair value |  | ​ | 110,856
​ | ​ | ​ | ​
Balance, September 30, 2020 |  | $ | 127,376
Change in fair value |  | ​ | 470,132
​ | ​ | ​ | ​
Balance, June 30, 2021 |  | $ | 597,508
​ | ​ | ​ | ​
Derivatives with expected life of less than one year |  | $ | —
Derivatives with expected life greater than one year |  | $ | 597,508
​

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration